To this end, two candidate anti - angiogenic RNA - damaging agents, onconase and ( - 4) rhEDN, were screened for their effects on endothelial cell proliferation using three distinct types of endothelial cells in culture: HPV - 16 E6 / E7 - immortalized human umbilical vein endothelial cells ( HUVECs), a Kras - transformed HPV - 16 E6 / E7 HUVEC ( Rhim et al., Carcinogenesis 4, 673 - 681, 1998), and primary HUVECs.	"onconase	68	76	Chemical"	"endothelial cell	130	146	Cell"	"endothelial cells	191	208	Cell"	"HPV - 16 E6	221	232	Organism"	"E7	235	237	Organism"	"human umbilical vein endothelial cells	253	291	Cell"	"HUVECs	294	300	Cell"	"Kras	305	309	Gene_or_gene_product"	"HPV - 16 E6	324	335	Organism"	"E7	338	340	Organism"	"HUVEC	341	346	Cell"	"HUVECs	410	416	Cell"	"[{""token"": ""onconase"", ""start_span"": 68, ""end_span"": 76, ""type"": ""Chemical""}, {""token"": ""endothelial cell"", ""start_span"": 130, ""end_span"": 146, ""type"": ""Cell""}, {""token"": ""endothelial cells"", ""start_span"": 191, ""end_span"": 208, ""type"": ""Cell""}, {""token"": ""HPV - 16 E6"", ""start_span"": 221, ""end_span"": 232, ""type"": ""Organism""}, {""token"": ""E7"", ""start_span"": 235, ""end_span"": 237, ""type"": ""Organism""}, {""token"": ""human umbilical vein endothelial cells"", ""start_span"": 253, ""end_span"": 291, ""type"": ""Cell""}, {""token"": ""HUVECs"", ""start_span"": 294, ""end_span"": 300, ""type"": ""Cell""}, {""token"": ""Kras"", ""start_span"": 305, ""end_span"": 309, ""type"": ""Gene_or_gene_product""}, {""token"": ""HPV - 16 E6"", ""start_span"": 324, ""end_span"": 335, ""type"": ""Organism""}, {""token"": ""E7"", ""start_span"": 338, ""end_span"": 340, ""type"": ""Organism""}, {""token"": ""HUVEC"", ""start_span"": 341, ""end_span"": 346, ""type"": ""Cell""}, {""token"": ""HUVECs"", ""start_span"": 410, ""end_span"": 416, ""type"": ""Cell""}]"
A clone of NIH3T3 transformant ( H - 3), obtained by transfecting genomic DNA of a human colon carcinoma cell line, contains human K - ras oncogene and yields metastatic pulmonary nodules after intravenous injection of the cells into nude mice.	"clone	2	7	Cell"	"NIH3T3 transformant	11	30	Cell"	"H - 3	33	38	Cell"	"DNA	74	77	Cellular_component"	"human	83	88	Organism"	"colon carcinoma cell line	89	114	Cell"	"human	125	130	Organism"	"K - ras	131	138	Gene_or_gene_product"	"pulmonary nodules	170	187	Pathological_formation"	"intravenous	194	205	Immaterial_anatomical_entity"	"cells	223	228	Cell"	"nude mice	234	243	Organism"	"[{""token"": ""clone"", ""start_span"": 2, ""end_span"": 7, ""type"": ""Cell""}, {""token"": ""NIH3T3 transformant"", ""start_span"": 11, ""end_span"": 30, ""type"": ""Cell""}, {""token"": ""H - 3"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Cell""}, {""token"": ""DNA"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Cellular_component""}, {""token"": ""human"", ""start_span"": 83, ""end_span"": 88, ""type"": ""Organism""}, {""token"": ""colon carcinoma cell line"", ""start_span"": 89, ""end_span"": 114, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Organism""}, {""token"": ""K - ras"", ""start_span"": 131, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""pulmonary nodules"", ""start_span"": 170, ""end_span"": 187, ""type"": ""Pathological_formation""}, {""token"": ""intravenous"", ""start_span"": 194, ""end_span"": 205, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""cells"", ""start_span"": 223, ""end_span"": 228, ""type"": ""Cell""}, {""token"": ""nude mice"", ""start_span"": 234, ""end_span"": 243, ""type"": ""Organism""}]"
After decapitation of the rats, trunk blood was obtained, and the ileum, liver, and kidney were removed for histological examination and for the measurement of malondialdehyde ( MDA) and glutathione ( GSH) levels, myeloperoxidase ( MPO) activity, and collagen content.	"rats	26	30	Organism"	"trunk blood	32	43	Organism_substance"	"ileum	66	71	Multi"	"liver	73	78	Organ"	"kidney	84	90	Organ"	"malondialdehyde	160	175	Chemical"	"MDA	178	181	Chemical"	"glutathione	187	198	Chemical"	"GSH	201	204	Chemical"	"myeloperoxidase	214	229	Chemical"	"MPO	232	235	Chemical"	"collagen	251	259	Gene_or_gene_product"	"[{""token"": ""rats"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Organism""}, {""token"": ""trunk blood"", ""start_span"": 32, ""end_span"": 43, ""type"": ""Organism_substance""}, {""token"": ""ileum"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Multi""}, {""token"": ""liver"", ""start_span"": 73, ""end_span"": 78, ""type"": ""Organ""}, {""token"": ""kidney"", ""start_span"": 84, ""end_span"": 90, ""type"": ""Organ""}, {""token"": ""malondialdehyde"", ""start_span"": 160, ""end_span"": 175, ""type"": ""Chemical""}, {""token"": ""MDA"", ""start_span"": 178, ""end_span"": 181, ""type"": ""Chemical""}, {""token"": ""glutathione"", ""start_span"": 187, ""end_span"": 198, ""type"": ""Chemical""}, {""token"": ""GSH"", ""start_span"": 201, ""end_span"": 204, ""type"": ""Chemical""}, {""token"": ""myeloperoxidase"", ""start_span"": 214, ""end_span"": 229, ""type"": ""Chemical""}, {""token"": ""MPO"", ""start_span"": 232, ""end_span"": 235, ""type"": ""Chemical""}, {""token"": ""collagen"", ""start_span"": 251, ""end_span"": 259, ""type"": ""Gene_or_gene_product""}]"
The mice that received Hoxa9 / Meis1 - transduced bone marrow cells developed acute myeloid leukemia ( AML), and Trib1, Evi1, Ahi1, Raralpha, Pitpnb, and AK039950 were identified as candidate cooperative genes located near common retroviral integration sites.	"mice	4	8	Organism"	"Hoxa9	23	28	Gene_or_gene_product"	"Meis1	31	36	Gene_or_gene_product"	"bone marrow cells	50	67	Cell"	"acute myeloid leukemia	78	100	Cancer"	"AML	103	106	Cancer"	"Trib1	113	118	Gene_or_gene_product"	"Evi1	120	124	Gene_or_gene_product"	"Ahi1	126	130	Gene_or_gene_product"	"Raralpha	132	140	Gene_or_gene_product"	"Pitpnb	142	148	Gene_or_gene_product"	"AK039950	154	162	Gene_or_gene_product"	"[{""token"": ""mice"", ""start_span"": 4, ""end_span"": 8, ""type"": ""Organism""}, {""token"": ""Hoxa9"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""Meis1"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""bone marrow cells"", ""start_span"": 50, ""end_span"": 67, ""type"": ""Cell""}, {""token"": ""acute myeloid leukemia"", ""start_span"": 78, ""end_span"": 100, ""type"": ""Cancer""}, {""token"": ""AML"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Cancer""}, {""token"": ""Trib1"", ""start_span"": 113, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""Evi1"", ""start_span"": 120, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ahi1"", ""start_span"": 126, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""Raralpha"", ""start_span"": 132, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}, {""token"": ""Pitpnb"", ""start_span"": 142, ""end_span"": 148, ""type"": ""Gene_or_gene_product""}, {""token"": ""AK039950"", ""start_span"": 154, ""end_span"": 162, ""type"": ""Gene_or_gene_product""}]"
The mechanism of caffeine seems to involve the inhibition of the extracellular signal - regulated kinase 1 / 2 ( ERK1 / 2), p38, and Akt, leading to a marked decrease in adenosine - induced HIF - 1alpha accumulation, VEGF transcriptional activation, and VEGF and IL - 8 protein accumulation.	"caffeine	17	25	Chemical"	"extracellular signal - regulated kinase 1	65	106	Gene_or_gene_product"	"2	109	110	Gene_or_gene_product"	"ERK1	113	117	Gene_or_gene_product"	"2	120	121	Gene_or_gene_product"	"p38	124	127	Gene_or_gene_product"	"Akt	133	136	Gene_or_gene_product"	"adenosine	170	179	Chemical"	"HIF - 1alpha	190	202	Gene_or_gene_product"	"VEGF	217	221	Gene_or_gene_product"	"VEGF	254	258	Gene_or_gene_product"	"IL - 8	263	269	Gene_or_gene_product"	"[{""token"": ""caffeine"", ""start_span"": 17, ""end_span"": 25, ""type"": ""Chemical""}, {""token"": ""extracellular signal - regulated kinase 1"", ""start_span"": 65, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""2"", ""start_span"": 109, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK1"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}, {""token"": ""2"", ""start_span"": 120, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}, {""token"": ""p38"", ""start_span"": 124, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 133, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}, {""token"": ""adenosine"", ""start_span"": 170, ""end_span"": 179, ""type"": ""Chemical""}, {""token"": ""HIF - 1alpha"", ""start_span"": 190, ""end_span"": 202, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 217, ""end_span"": 221, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 254, ""end_span"": 258, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 8"", ""start_span"": 263, ""end_span"": 269, ""type"": ""Gene_or_gene_product""}]"
VPF / VEGF induced dermal microvascular EC expression of mRNAs encoding the alphav and beta3 integrin subunits resulting in increased levels of the alphavbeta3 heterodimer at the cell surface, and VPF / VEGF also induced mRNA encoding osteopontin ( OPN), an alphavbeta3 ligand.	"VPF	0	3	Gene_or_gene_product"	"VEGF	6	10	Gene_or_gene_product"	"dermal microvascular EC	19	42	Cell"	"alphav	76	82	Gene_or_gene_product"	"beta3 integrin subunits	87	110	Gene_or_gene_product"	"alphavbeta3	148	159	Gene_or_gene_product"	"cell surface	179	191	Cellular_component"	"VPF	197	200	Gene_or_gene_product"	"VEGF	203	207	Gene_or_gene_product"	"osteopontin	235	246	Gene_or_gene_product"	"OPN	249	252	Gene_or_gene_product"	"alphavbeta3	258	269	Gene_or_gene_product"	"[{""token"": ""VPF"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 6, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""dermal microvascular EC"", ""start_span"": 19, ""end_span"": 42, ""type"": ""Cell""}, {""token"": ""alphav"", ""start_span"": 76, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta3 integrin subunits"", ""start_span"": 87, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""alphavbeta3"", ""start_span"": 148, ""end_span"": 159, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell surface"", ""start_span"": 179, ""end_span"": 191, ""type"": ""Cellular_component""}, {""token"": ""VPF"", ""start_span"": 197, ""end_span"": 200, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 203, ""end_span"": 207, ""type"": ""Gene_or_gene_product""}, {""token"": ""osteopontin"", ""start_span"": 235, ""end_span"": 246, ""type"": ""Gene_or_gene_product""}, {""token"": ""OPN"", ""start_span"": 249, ""end_span"": 252, ""type"": ""Gene_or_gene_product""}, {""token"": ""alphavbeta3"", ""start_span"": 258, ""end_span"": 269, ""type"": ""Gene_or_gene_product""}]"
Expression of the cytolytic effectors perforin, granzyme B9, and the granule membrane protein TIA1 were examined in 24 putative NK - cell lymphomas, 18 postthymic T - cell lymphomas ( one case CD8 + CD56 + and three anaplastic large cell lymphomas ( ALCL), three T - lymphoblastic lymphomas, and 20 B - cell lymphomas.	"perforin	38	46	Gene_or_gene_product"	"granzyme B9	48	59	Gene_or_gene_product"	"granule membrane	69	85	Cellular_component"	"TIA1	94	98	Gene_or_gene_product"	"NK - cell lymphomas	128	147	Cancer"	"T - cell lymphomas	163	181	Cancer"	"CD8	193	196	Gene_or_gene_product"	"CD56	199	203	Gene_or_gene_product"	"anaplastic large cell lymphomas	216	247	Cancer"	"ALCL	250	254	Cancer"	"T - lymphoblastic lymphomas	263	290	Cancer"	"B - cell lymphomas	299	317	Cancer"	"[{""token"": ""perforin"", ""start_span"": 38, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""granzyme B9"", ""start_span"": 48, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""granule membrane"", ""start_span"": 69, ""end_span"": 85, ""type"": ""Cellular_component""}, {""token"": ""TIA1"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""NK - cell lymphomas"", ""start_span"": 128, ""end_span"": 147, ""type"": ""Cancer""}, {""token"": ""T - cell lymphomas"", ""start_span"": 163, ""end_span"": 181, ""type"": ""Cancer""}, {""token"": ""CD8"", ""start_span"": 193, ""end_span"": 196, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD56"", ""start_span"": 199, ""end_span"": 203, ""type"": ""Gene_or_gene_product""}, {""token"": ""anaplastic large cell lymphomas"", ""start_span"": 216, ""end_span"": 247, ""type"": ""Cancer""}, {""token"": ""ALCL"", ""start_span"": 250, ""end_span"": 254, ""type"": ""Cancer""}, {""token"": ""T - lymphoblastic lymphomas"", ""start_span"": 263, ""end_span"": 290, ""type"": ""Cancer""}, {""token"": ""B - cell lymphomas"", ""start_span"": 299, ""end_span"": 317, ""type"": ""Cancer""}]"
